Gala vs Maximus: Which GLP-1 Provider Is Better?
Short answer: Gala scores higher on our rubric, 7.2/10 against 5.1/10. Full reasoning, pricing and the cases where the other one wins are below.
Gala beats Maximus overall, scoring 7.2/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; Maximus is published $79.99/mo; total not verified. Choose Gala for patients who want gala's low yearly-plan rate on compounded glp-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging. Choose Maximus for men who want glp-1 alongside testosterone or other men's health protocols.
A side-by-side look at Gala and Maximus to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Gala
#30 of 54Telehealth platform whose compounded GLP-1 line covers semaglutide and tirzepatide, sold as a $149/mo microdose tier and a $179/mo all-doses tier, alongside brand-name Ozempic at $1,299/mo and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. of Wilmington, Delaware, with care delivered by OpenLoop-affiliated medical groups; Gala states it provides administrative, technology and management services and does not itself provide medical care. It is LegitScript verified and promotes a free Gala GLP-1 app for in-treatment dosing, weight and side-effect logging.
Visit GalaMaximus
#48 of 54Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.
Visit Maximus| Feature | Gala | Maximus |
|---|---|---|
| Why each one | A free Gala GLP-1 companion app, paired with a $149/mo microdose tirzepatide tier on a yearly commitment plan; confirm the app's availability for your phone before enrolling. | Only platform offering GLP-1 microdosing from $79.99/mo for BMI as low as 22, targeting the 'small weight loss' and metabolic health market. |
| Our Score | 7.2/10 | 5.1/10 |
| Headline Price | from $149/mo | published $79.99/mo; total not verified |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Patients who want Gala's low yearly-plan rate on compounded GLP-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging | Men who want GLP-1 alongside testosterone or other men's health protocols |
| Watch out for | Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line. | The advertised rates are first cycle prices. Compounded semaglutide steps up from $149.99 to $249.99 a month once the first cycle ends, and tirzepatide from $259.99 to $359.99, with lab work billed on top at $99 for the at-home kit or $19.99 to $115 for a Quest draw |
| Ranking | #30 | #48 |
| Get started | Visit Gala | Visit Maximus |
Pros & Cons Compared
Gala
Pros
- +Compounded GLP-1 is $149/mo on the microdose tier or $179/mo with all doses included on the yearly plan, and Gala's about page lists GLP-1 medication from $199/mo on a 3-month plan
- +A free Gala GLP-1 app for in-treatment logging, promoted in the footer of every page; first-party logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.
- −Product pages quote only the yearly subscription, its about page lists a 3-month GLP-1 plan from $199/mo, and the plan you actually get is set at checkout after you log in
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
- −Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and Gala publishes no lab panel for the GLP-1 program, no named medical director and no specialty obesity oversight; its refund policy does list lab services among what the subscription price may cover
- −Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
Maximus
Pros
- +Advertised starting rate of $79.99/mo for compounded semaglutide, among the lowest headline prices we track; the same page also shows $150 per month, and lab work is billed separately
- +Compounded plans are flat rate across every dose, so titrating up does not reprice your plan
- +Maximus adds glycine and B12 to its compounded semaglutide, described on the site as a way to further customize and tailor the medication; it cites no clinical evidence for the combination
- +Free expedited shipping on all medication orders
Cons
- −The advertised rates are first cycle prices. Compounded semaglutide steps up from $149.99 to $249.99 a month once the first cycle ends, and tirzepatide from $259.99 to $359.99, with lab work billed on top at $99 for the at-home kit or $19.99 to $115 for a Quest draw
- −The fulfilling pharmacies are named only as initials in the help center, EVR, FCC or VIOS by state for compounded medication and The Pharmacy Hub for brand-name, and not on the product pages a shopper actually reads
- −Brand-name plans are priced by dose tier, so titrating up can move you to a higher monthly rate; compounded plans stay flat across all doses
- −FDA warning letter #730095, issued June 8, 2026, cites false or misleading compounded-GLP-1 marketing claims. It is a marketing/misbranding record, not an unsafe-medication finding
Our Verdict
Gala edges out Maximus with a score of 7.2/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; Maximus is published $79.99/mo; total not verified.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Gala and Maximus.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Gala and GoodRx Care$119/mo subscription + medication
- Compare Gala and Tonik Wellnessfrom $149/mo
- Compare Gala and Willow$299 first month, then $499/mo
- Compare Maximus and Bodybuilding Health+$179/mo month-to-month
- Compare Maximus and Trimi Health$175/mo month-to-month
- Compare Maximus and MEDGm$179 first month, rises after
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Gala legit and is Maximus legit, with the verification evidence behind each answer.
Our pick of these two: Gala · 7.2/10